Patterns of drug use are changing, as are societal responses to the drug ‘problem’. In itself, this is not particularly noteworthy. However, in many ways we are experiencing change that is unprecedented in the history of drug policy. Many new developments are occurring simultaneously: technological advances enable new ways of producing and distributing both old and new drugs, and facilitate the dissemination of information that influences drug-taking behaviours. Those who seek to respond (including policy makers, treatment professionals, researchers) also harness scientific advances. The rate of change is such that it is difficult to keep up, or to predict the consequences.
This book examines change and continuity in European drug scenes. Eight original research papers explore their own specific topics, features on the broader drug landscape. But individually and (especially) together, these studies provide broader insights relevant to many other aspects of the contemporary drug scene in Europe and beyond.